{
    "nctId": "NCT02509091",
    "officialTitle": "Clinical Efficacy and Safety of Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis:An Open-label Randomized Parallel Controlled Study",
    "inclusionCriteria": "1. Age\u226518 years and \u226480 years;\n2. Patients with non-cystic fibrosis bronchiectasis diagnosed by high-resolution CT;\n3. Are sensitive to amikacin;\n4. Acute exacerbation of bronchiectasis;\n5. Capable of the completion of bronchoscopy, alveolar lavage, pulmonary function testing etc;\n6. Willing to join in and sign the informed consent form.\n* Must have minimum age of 18 Years\n* Must have maximum age of 80 Years",
    "exclusionCriteria": "1. Active bleeding without control\uff1b\n2. Receiving nasal or facial surgery recently\uff1b\n3. With severe cardio-pulmonary dysfunction, such as left heart failure, unstable arrhythmia, etc.\n4. With other respiratory diseases: such as active pulmonary tuberculosis, non-tuberculosis mycobacteria (NTM) pulmonary disease, pulmonary aspergillosis, etc.\n5. Be allergic to amikacin"
}